Join us in the fascinating, world class National Institute for Bioprocessing Research and Training to learn how Analytics and AI is being employed by global leading companies in Health Science to revolutionise the industry.
Our speakers include:
Frank Cordes, Partner and Managing Director, Boston Consulting Group
Frank Cordes is a Partner in the London office of The Boston Consulting Group. Frank leads the firm’s Operations practice in Western Europe and South America, BCG’s Biopharma Operations team in Europe and the topic of Digital Operations in biopharmaceutical operations globally.
Today, Frank is working with biopharmaceutical manufacturers on applying Digital technology and Advanced Analytics to improve their Supply Chain and Manufacturing performance. He has overseen several Digital Supply Chain implementations, the design and implementation of digitally enabled Production Systems as well as a range of analytics and AI-driven projects focused on the release of capacity constraints, quality improvements or cost savings.
Frank has a DPhil and MSc in Molecular Biophysics from the University of Oxford. He is a German national and studied at the Freie Universität in Berlin, at the Ecole Normale Supérieure in Paris and at Oxford University.
Dr Colin Clarke, Principal Investigator, National Institute for Bioprocessing Research and Training
Dr. Clarke graduated with a PhD in Bioinformatics from Cranfield University, UK, and specialises in the application of multivariate statistics and machine learning algorithms to high dimensional data. Upon completion of his doctoral training Colin took a position at Dublin Institute of Technology (DIT) applying chemometric approaches to analyse Raman and Infrared spectroscopy data from cells and tissues.
He moved to the National Institute for Cellular Biotechnology at Dublin City University in 2009.
In 2014 he moved to NIBRT following the award of SFI’s prestigious Starting Investigator Research Grant. Dr Clarke’s bioinformatics group is currently focussed on further understanding of the CHO cell biological system using next generation sequencing and advanced computational techniques.
Speaker from Nuritas (TBC)